National Institute of Dental and Craniofacial Research; Interagency Pain Research Coordinating Committee; Call for Nominations, 65495 [2010-26937]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 205 / Monday, October 25, 2010 / Notices
national and State statistics on public
and private residential services for
individuals with intellectual and
developmental disabilities, including
disaggregation of data related to specific
demographic groups. The project will
conduct analyses that describe the
movement of individuals with
intellectual and developmental
disabilities from institutional to
community settings. Project staff will
also participate in collaborative efforts
with ADD and other data collection
projects to review and report on unmet
needs in data collection, analyses, and
reporting activities that would promote
the self-determination, independence,
productivity, and integration and
inclusion of people with intellectual
and developmental disabilities in all
facets of community life.
Contact for Further Information:
Ophelia McLain, Supervisory Program
Specialist, Administration on
Developmental Disabilities, 370
L’Enfant Promenade, SW., Mail Stop:
HHH–405D, Washington, DC 20447.
Telephone: 202–690–7025 E-mail:
ophelia.mclain@acf.hhs.gov.
Dated: October 14, 2010.
Sharon Lewis,
Commissioner, Administration on
Developmental Disabilities.
[FR Doc. 2010–26933 Filed 10–22–10; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
emcdonald on DSK2BSOYB1PROD with NOTICES
National Institute of Dental and
Craniofacial Research; Interagency
Pain Research Coordinating
Committee; Call for Nominations
The Department of Health and Human
Services has created the Interagency
Pain Research Coordinating Committee
and is seeking nominations for this
committee. As specified in Public Law
111–148 (‘‘Patient Protection and
Affordable Care Act’’) the Committee
will: (a) Develop a summary of advances
in pain care research supported or
conducted by the Federal agencies
relevant to the diagnosis, prevention,
and treatment of pain and diseases and
disorders associated with pain; (b)
identify critical gaps in basic and
clinical research on the symptoms and
causes of pain; (c) make
recommendations to ensure that the
activities of the National Institutes of
Health and other Federal agencies are
free of unnecessary duplication of effort;
(d) make recommendations on how best
to disseminate information on pain care;
VerDate Mar<15>2010
16:05 Oct 22, 2010
Jkt 223001
and (e) make recommendations on how
to expand partnerships between public
entities and private entities to expand
collaborative, cross-cutting research.
Membership on the committee will
include six (6) non-Federal members
from among scientists, physicians, and
other health professionals and six (6)
non-Federal members of the general
public who are representatives of
leading research, advocacy, and service
organizations for individuals with painrelated conditions. Members will serve
overlapping three year terms. It is
anticipated that the committee will meet
at least once a year.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of women, all ethnic and racial groups,
and people with disabilities are
represented on HHS Federal advisory
committees and, therefore, the
Department encourages nominations of
qualified candidates from these groups.
The Department also encourages
geographic diversity in the composition
of the Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
Nominations are due by COB
November 26, 2010, and should be sent
to Amy Adams, PhD, NIDCR/NIH, 31
Center Drive, Room 5B55, MSC–2190,
Bethesda MD 20892–2190,
adamsamy@mail.nih.gov by either
USPS mail or e-mail. Nominations
should include contact information and
a current curriculum vitae or resume.
Dated: October 18, 2010.
Amy Adams,
National Institute of Dental and Craniofacial
Research, National Institutes of Health.
[FR Doc. 2010–26937 Filed 10–22–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0529]
Draft Guidance for Industry on
Qualification Process for Drug
Development Tools; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
65495
availability of a draft guidance for
industry entitled ‘‘Qualification Process
for Drug Development Tools.’’ This draft
guidance describes the qualification
process for drug development tools
(DDTs) intended for potential use, over
time, in multiple drug development
programs. The draft guidance provides a
framework for interactions between the
Center for Drug Evaluation and Research
(CDER) and DDT sponsors to support
work towards qualification of an
identified DDT and creates a mechanism
for formal review of data by CDER to
qualify the DDT and ensure that the
evaluation is comprehensive and
reliable.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by January 24,
2011.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 2201,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance document.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Shaniece Gathers, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 21, rm. 4555,
Silver Spring, MD 20993–0002, 301–
796–2600.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a draft guidance for industry entitled
‘‘Qualification Process for Drug
Development Tools.’’ In March 2006,
FDA issued the ‘‘Critical Path
Opportunities Report’’ and the ‘‘Critical
Path Opportunities List.’’ In these
reports, FDA described six key areas
along the critical path to improved
therapies, and a list of specific
opportunities for advancement within
these topic areas. The opportunities
report noted that a new product
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 75, Number 205 (Monday, October 25, 2010)]
[Notices]
[Page 65495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26937]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research;
Interagency Pain Research Coordinating Committee; Call for Nominations
The Department of Health and Human Services has created the
Interagency Pain Research Coordinating Committee and is seeking
nominations for this committee. As specified in Public Law 111-148
(``Patient Protection and Affordable Care Act'') the Committee will:
(a) Develop a summary of advances in pain care research supported or
conducted by the Federal agencies relevant to the diagnosis,
prevention, and treatment of pain and diseases and disorders associated
with pain; (b) identify critical gaps in basic and clinical research on
the symptoms and causes of pain; (c) make recommendations to ensure
that the activities of the National Institutes of Health and other
Federal agencies are free of unnecessary duplication of effort; (d)
make recommendations on how best to disseminate information on pain
care; and (e) make recommendations on how to expand partnerships
between public entities and private entities to expand collaborative,
cross-cutting research.
Membership on the committee will include six (6) non-Federal
members from among scientists, physicians, and other health
professionals and six (6) non-Federal members of the general public who
are representatives of leading research, advocacy, and service
organizations for individuals with pain-related conditions. Members
will serve overlapping three year terms. It is anticipated that the
committee will meet at least once a year.
The Department strives to ensure that the membership of HHS Federal
advisory committees is fairly balanced in terms of points of view
represented and the committee's function. Every effort is made to
ensure that the views of women, all ethnic and racial groups, and
people with disabilities are represented on HHS Federal advisory
committees and, therefore, the Department encourages nominations of
qualified candidates from these groups. The Department also encourages
geographic diversity in the composition of the Committee. Appointment
to this Committee shall be made without discrimination on the basis of
age, race, ethnicity, gender, sexual orientation, disability, and
cultural, religious, or socioeconomic status.
Nominations are due by COB November 26, 2010, and should be sent to
Amy Adams, PhD, NIDCR/NIH, 31 Center Drive, Room 5B55, MSC-2190,
Bethesda MD 20892-2190, adamsamy@mail.nih.gov by either USPS mail or e-
mail. Nominations should include contact information and a current
curriculum vitae or resume.
Dated: October 18, 2010.
Amy Adams,
National Institute of Dental and Craniofacial Research, National
Institutes of Health.
[FR Doc. 2010-26937 Filed 10-22-10; 8:45 am]
BILLING CODE 4140-01-P
